Manufacturing

Vincenza Pironti, PhD,is strategic marketing director at Recipharm.

Articles

The rising demand for biologics and technological innovations are driving blow-fill-seal capacity, harnessing manufacturing efficiency, and benefitting patients.

Leveraging Blow-Fill-Seal Technology for Biologic Delivery

Feliza Mirasol is the science editor for 

Videos

At INTERPHEX 2024, BioPharm International spoke with Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, at STERIS Life Sciences, about how to effectively conduct sterile powder transfer during the fill/finish step in parenteral drug product manufacturing.

A Deep Dive on Sterile Powder Transfer for Parenteral Fill/Finish (INTERPHEX 2024)

CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.

Installation of Cytiva’s Aseptic Filling Workcell Aimed at Raising White Raven’s Manufacturing Efficiency

The Italian company’s North American business has seen an increase of 47%.

Bormioli Pharma Increases Capacity in North America

Editor of Pharmaceutical Technology Europe

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Automating the Future of Fill/Finish

The partnership will allow for both companies to provide end-to-end biopharmaceutical manufacturing solutions.

BioCina and NovaCina to Partner on Drug Substance and Product Solutions for Biologics

The document includes recommendations for the reporting and implementation of changes to container closure system components.

FDA Publishes Guidance on Container Closure Systems for COVID-19 

Biosynth has further strengthened its peptide division with the acquisition of  Pepceuticals.

Biosynth Strengthens Position in Peptide Field through Pepceuticals Acquisition

With the acquisition, Sharp plans on offering fully integrated small-to-medium scale sterile injectable services.

Sharp Acquires Berkshire Sterile Manufacturing

Chris Spivey is the editorial director of 

Drug efficacy, reputation, and financial return are all on the line when it comes to fill/finish.   

Manufacturing, Fill/Finish